Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
13.19
-1.41 (-9.66%)
Apr 29, 2026, 2:50 PM EDT - Market open
Tenax Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 97.57 | 94.85 | 9.79 | 2.12 | 5.58 | Upgrade
|
| Cash & Short-Term Investments | 97.57 | 94.85 | 9.79 | 2.12 | 5.58 | Upgrade
|
| Cash Growth | 2.86% | 868.66% | 361.09% | -61.97% | -16.82% | Upgrade
|
| Prepaid Expenses | 5.64 | 1.77 | 1.64 | 0.74 | 0.11 | Upgrade
|
| Other Current Assets | 1.02 | 0.06 | 0.25 | 0.35 | - | Upgrade
|
| Total Current Assets | 104.23 | 96.69 | 11.68 | 3.21 | 5.69 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0.19 | 0.29 | Upgrade
|
| Other Long-Term Assets | - | - | 0 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 104.23 | 96.69 | 11.69 | 3.4 | 5.99 | Upgrade
|
| Accounts Payable | 6.04 | 3.16 | 2.07 | 0.45 | 0.86 | Upgrade
|
| Accrued Expenses | 1.12 | 1.54 | 1.01 | 0.66 | 0.6 | Upgrade
|
| Short-Term Debt | - | - | 0.5 | 0.62 | - | Upgrade
|
| Current Portion of Leases | - | - | - | 0.12 | 0.11 | Upgrade
|
| Total Current Liabilities | 7.16 | 4.69 | 3.59 | 1.85 | 1.56 | Upgrade
|
| Long-Term Leases | - | - | - | 0.06 | 0.18 | Upgrade
|
| Total Liabilities | 7.16 | 4.69 | 3.59 | 1.91 | 1.75 | Upgrade
|
| Common Stock | 0 | - | - | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 464.52 | 406.85 | 305.35 | 291.03 | 282.74 | Upgrade
|
| Retained Earnings | -367.45 | -314.86 | -297.25 | -289.54 | -278.49 | Upgrade
|
| Total Common Equity | 97.07 | 91.99 | 8.1 | 1.49 | 4.24 | Upgrade
|
| Shareholders' Equity | 97.07 | 91.99 | 8.1 | 1.49 | 4.24 | Upgrade
|
| Total Liabilities & Equity | 104.23 | 96.69 | 11.69 | 3.4 | 5.99 | Upgrade
|
| Total Debt | - | - | 0.5 | 0.81 | 0.29 | Upgrade
|
| Net Cash (Debt) | 97.57 | 94.85 | 9.29 | 1.32 | 5.29 | Upgrade
|
| Net Cash Growth | 2.86% | 920.89% | 606.12% | -75.14% | -17.40% | Upgrade
|
| Net Cash Per Share | 2.49 | 6.21 | 37.40 | 71.55 | 411.57 | Upgrade
|
| Filing Date Shares Outstanding | 50.3 | 35.85 | 1.96 | 0.35 | 0.02 | Upgrade
|
| Total Common Shares Outstanding | 42.42 | 35.3 | 0.3 | 0.03 | 0.02 | Upgrade
|
| Working Capital | 97.07 | 91.99 | 8.1 | 1.36 | 4.13 | Upgrade
|
| Book Value Per Share | 2.29 | 2.61 | 27.15 | 52.11 | 269.43 | Upgrade
|
| Tangible Book Value | 97.07 | 91.99 | 8.1 | 1.49 | 4.24 | Upgrade
|
| Tangible Book Value Per Share | 2.29 | 2.61 | 27.15 | 52.11 | 269.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.